Sanofi targets 50% faster drug development with AI

Sanofi aims to cut drug development timelines from 10-12 years to 5-6 years using AI, according to Chief Digital Officer Emmanuel Frenehard. The pharma giant is using AI to simulate clinical trials before they happen, improving patient selection and trial precision. Central to this strategy is treating Snowflake as an operating system rather than a database, consolidating all data into a single governed platform. Frenehard argues that fragmented data undermines AI precision, and that unified, AI-ready data is the prerequisite for transforming pharmaceutical workflows at enterprise scale.